Adverse Drug Reactions and Pharmacovigilance of Herbal Medicines in India
Abstract
The use of ayurvedic medicines is popular in India and in recent times has become accepted in other countries. Associated with this increasing use, are growing concerns about the safety of ayurvedic medicines. This paper discusses in brief the ayurvedic concepts of adverse reactions to medicines, the need for pharmacovigilance of ayurvedic medicines, challenges in introducing pharmacovigilance in ayurveda and some recommendations to successfully implement these activities. Pharmacovigilance is the science and practice related to the detection, assessment, understanding and prevention of adverse effects of drugs or any other possible drug-related problems. The objective of the present article is to review the recent trends and challenges posed in the practice of pharmacovigilance of herbal drugs especially in the Indian context and to shed light on the importance of pharmacovigilance practice in establishing and maintenance of rational use of these drugs. There is increasing awareness of the need to develop pharmacovigilance for herbal medicines. Applying standard pharmacovigilance techniques (WHO guidelines) presents additional challenges, related to the ways in which herbal medicines are regulated, used, named, and perceived. Proper reporting of suspected adverse drug reactions (ADRs) to herbal medicines is currently the main method of detection. However, there is under-reporting for herbal medicines, since users do not seek professional advice about their use of such products, or report adverse effects. Herbal medicine practitioners are not recognized as reporters to spontaneous reporting schemes. Several other conventional pharmacovigilance tools, such as prescription-event monitoring and the use of computerized health record databases, are currently of little use for evaluating the safety of herbal medicines, although modified methods have been developed. This process of pharmacovigilance of herbals in India has come a long way since its initiation. The promotion of systematic and rational use of drugs requires the reporting of adverse events possibly caused by herbal and traditional medicines also.
Keywords
References
Ganesh Krishna Gadre, editor. Ashtang Hridaya. 13th Adhyaya, 2nd Edn. Pune: Aryabhushan Printing Press; 1910; 65p.
Thatte UM, Rege NN, Phatak S, et al. The Flip Side of Ayurveda? J Postgrad Med. 1993; 39: 179–82p.
Acharya Jadavji Trikramji, editor. Charak Samhita. 8th Adhyaya, 5th Edn. Varanasi: Chaukhambha Sanskrit Sansthan; 2001; 275p.
Acharya Jadavji Trikramji, editor. Charak Samhita. 8th Adhyaya, 5th Edn. Varanasi: Chaukhambha Sanskrit Sansthan; 2001; 276p.
Pandit Kashinath Shastri, editor. Rasantarangini. 2nd Adhyaya, 11th Edn. New Delhi: Sri Jainendra Press; 1994; 22–4p.
Malik V, editor. Drugs and Cosmetic Act, 1940. 4th Chapter, Part I. 14th Edn. Lucknow: Eastern Book Company; 2002; 37–44p.
Dahanukar SA, Thatte UM. Can We Prescribe Ayurvedic Drugs Rationally? Indian Pract. 1998; 51: 882–6p.
Gogtay NJ, Bhatt HA, Dalvi SS, et al. The Use and Safety of Non-Allopathic Indian Medicines. Drug Saf. 2002; 25: 1005–19p.
Saper RB, Kales SN, Paquin J, et al. Heavy Metal Content of Ayurvedic Herbal Medicine Products. JAMA. 2004; 292: 2868–73p.
Parab S, Kulkarni RA, Thatte UM. Heavy Metals in Herbal Medicines. Indian J Gastroenterol. 2003; 22: 111–2p.
Acharya Jadavji Trikramji, editor. Charak Samhita. 1st Adhyaya, 5th Edn. Varanasi: Chaukhambha Sanskrit Sansthan; 2001; 23p.
Parab SM, Kalele SS, Verma S, et al. Safety Issues with Medicines from Alternative System of Medicine. In: Proceedings of Workshop on Pharmacovigilance: Promoting Drug Safety through Collaboration; Parel, Mumbai: Seth GS Medical College. Dec 5–6, 2003; 22p.
Refbacks
- There are currently no refbacks.


